Bal Pharma Quarterly Results for Trading Insights
BALPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2025
Bal Pharma Quarterly Results Key Highlights
- Revenue of ₹75 Cr in Sept 2025 (-9.6% vs Mar 2025, +1.4% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025 (-80.0% vs Mar 2025, +0.0% vs Sept 2024)
- EBITDA of ₹7 Cr in Sept 2025 (-22.2% vs Mar 2025)
- Operating Margin of 8.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹0.45 in Sept 2025 (-86.8% vs Mar 2025)
Bal Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 75 | 83 | 67 | 74 | 97 | -9.6% | 1.4% |
| Net Profit (₹ Cr) | 1 | 5 | 0 | 1 | 6 | - | - |
| EBITDA (₹ Cr) | 7 | 9 | 7 | 8 | 12 | - | - |
| EPS (₹) | 0.45 | 3.40 | 0.13 | 0.65 | 3.73 | - | - |
| Operating Margin (%) | 8.0% | 9.0% | 9.0% | 10.0% | 10.0% | - | - |
Bal Pharma Share Price Trend Around Quarterly Results
Visualize Bal Pharma's 1-year price movement across quarterly results — ideal for logging trades in Bal Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Bal Pharma
Additional stock information and data for BALPHARMA
Revenue Trend (₹ Cr)
Sept 2024
74
Jun 2025
67
Mar 2025
83
Sept 2025
75
Net Profit Trend (₹ Cr)
Sept 2024
1
Jun 2025
0
Mar 2025
5
Sept 2025
1
Operating Margin Trend (%)
Sept 2024
10.0%
Jun 2025
9.0%
Mar 2025
9.0%
Sept 2025
8.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Bal Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores